20 min listen
E208 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre
FromNEI Podcast
ratings:
Length:
69 minutes
Released:
Dec 6, 2023
Format:
Podcast episode
Description
What were some new treatments approved by the FDA? What did we learn about the long-term safety of methylphenidate in childhood ADHD? Are there benefits to long-term maintenance treatment with antidepressants in bipolar disorder? What did we learn about the safety and efficacy of subcutaneous racemic ketamine for treatment-resistant depression and MDMA for PTSD? In this episode, Dr. Andrew Cutler and Dr. Roger McIntyre address these questions and so much more about this past year in psychopharmacology. Dr. Roger S. McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. Dr. McIntyre is involved in multiple research endeavors which primarily aim to characterize the association between mood disorders, notably cognitive function, and medical comorbidity. His work broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.
Released:
Dec 6, 2023
Format:
Podcast episode
Titles in the series (100)
E21 - Mental Wellness Month with Dr. Gary Small: Brain Health as We Age: As we continue our stimulating discussion of Mental Wellness Month, we interview Dr. Gary Small on how to maintain brain health as we age! Dr. Gary Small is a Longevity Lifestyle Geriatric psychiatrist and director of the UCLA Longevity... by NEI Podcast